Ignite Creation Date:
2025-12-25 @ 3:29 AM
Ignite Modification Date:
2026-05-16 @ 5:36 PM
Study NCT ID:
NCT00636805
Status:
TERMINATED
Last Update Posted:
2014-04-01
First Post:
2008-02-27
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Aloxi for Prevention of Chemotherapy Induced Nausea and Vomiting in Malignant Glioma Patients Receiving Irinotecan With Bevacizumab
Sponsor:
Duke University
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
Pro00002273
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None